Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.

about

Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.

Item

http://www.wikidata.org/entity/Q55346403

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.

@en

Inhibition of Tissue Factor Pathway Inhibitor

@nl

type

Item

label

Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.

@en

Inhibition of Tissue Factor Pathway Inhibitor

@nl

prefLabel

Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.

@en

Inhibition of Tissue Factor Pathway Inhibitor

@nl

P1476

Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.

@en

P275

Creative Commons Attribution-NonCommercial

P2860

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model

Calibrated automated thrombin generation measurement in clotting plasma

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains

Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice

Biology of tissue factor pathway inhibitor.

Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition

P2888

s40265-018-0922-6

P304

881-890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-018-0922-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pratima Chowdary

P5008

ScienceSource

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104290452

http://www.w3.org/2001/XMLSchema#string

P698

29845491

http://www.w3.org/2001/XMLSchema#string

P921

P932

6013504

http://www.w3.org/2001/XMLSchema#string